Mixed-method Estimation of Population-level HIV Viral Suppression Rate in the Western Cape, South Africa

Overview

Journal BMJ Glob Health

Specialty Public Health

Date 2020 Aug 21

PMID 32816953

Citations 3

Authors

Elton Mukonda

Nei-Yuan Hsiao

Lara Vojnov

Landon Myer

Maia Lesosky

Affiliations

Soon will be listed here.

Abstract

Introduction: There are few population-wide data on viral suppression (VS) that can be used to monitor programmatic targets in sub-Saharan Africa. We describe how routinely collected viral load (VL) data from antiretroviral therapy (ART) programmes can be extrapolated to estimate population VS and validate this using a combination of empiric and model-based estimates.

Methods: VL test results from were matched using a record linkage algorithm to obtain linked results for individuals. Test-level and individual-level VS rates were based on test VL values <1000 cps/mL, and individual VL <1000 cps/mL in a calendar year, respectively. We calculated population VS among people living with HIV (PLWH) in the province by combining census-derived midyear population estimates, HIV prevalence estimates and individual level VS estimates from routine VL data.

Results: Approximately 1.9 million VL test results between 2008 and 2018 were analysed. Among individuals in care, VS increased from 85.5% in 2008 to 90% in 2018. Population VS among all PLWH in the province increased from 12.2% in 2008 to 51.0% in 2017. The estimates derived from this method are comparable to those from other published studies. Sensitivity analyses showed that the results are robust to variations in linkage method, but sensitive to the extreme combinations of assumed VL testing coverage and population HIV prevalence.

Conclusion: While validation of this method in other settings is required, this approach provides a simple, robust method for estimating population VS using routine data from ART services that can be employed by national programmes in high-burden settings.

Citing Articles

Trends in continuity of treatment among children and adolescents living with HIV in 14 districts in South Africa from 2018-2023: A retrospective program analysis.

Mugisa B, Kehoe K, Silere-Maqetseba T, Mabasa H, Golin R, Chehab J IJID Reg. 2024; 13:100435.

PMID: 39308786 PMC: 11416216. DOI: 10.1016/j.ijregi.2024.100435.

Small area analysis of HIV viral load suppression patterns in a high priority district (2012-2016), South Africa.

Chimoyi L, Kufa T, Matsena-Zingoni Z, Marx F, Otwombe K, Musenge E PLOS Glob Public Health. 2023; 3(3):e0001728.

PMID: 37000713 PMC: 10065273. DOI: 10.1371/journal.pgph.0001728.

SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.

Lambarey H, Blumenthal M, Chetram A, Joyimbana W, Jennings L, Tincho M Viruses. 2022; 14(6).

PMID: 35746693 PMC: 9229655. DOI: 10.3390/v14061222.

References

Stover J, Walker N, Grassly N, Marston M . Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect. 2006; 82 Suppl 3:iii45-50. PMC: 2576732. DOI: 10.1136/sti.2006.020172. View

Tsai A, Siedner M . The Missing Men: HIV Treatment Scale-Up and Life Expectancy in Sub-Saharan Africa. PLoS Med. 2015; 12(11):e1001906. PMC: 4658175. DOI: 10.1371/journal.pmed.1001906. View

Chhim K, Mburu G, Tuot S, Sopha R, Khol V, Chhoun P . Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study. AIDS Res Ther. 2018; 15(1):20. PMC: 6240223. DOI: 10.1186/s12981-018-0205-z. View

Maman D, Chilima B, Masiku C, Ayouba A, Masson S, Szumilin E . Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study. J Int AIDS Soc. 2016; 19(1):20673. PMC: 4760102. DOI: 10.7448/IAS.19.1.20673. View

Gimbel S, Mwanza M, Nisingizwe M, Michel C, Hirschhorn L . Improving data quality across 3 sub-Saharan African countries using the Consolidated Framework for Implementation Research (CFIR): results from the African Health Initiative. BMC Health Serv Res. 2018; 17(Suppl 3):828. PMC: 5763292. DOI: 10.1186/s12913-017-2660-y. View

Huerga H, Van Cutsem G, Ben Farhat J, Puren A, Bouhenia M, Wiesner L . Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey. BMC Public Health. 2018; 18(1):303. PMC: 5833029. DOI: 10.1186/s12889-018-5208-0. View

Sharma M, Barnabas R, Celum C . Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa. PLoS Med. 2017; 14(4):e1002262. PMC: 5388461. DOI: 10.1371/journal.pmed.1002262. View

Abuelezam N, McCormick A, Surface E, Fussell T, Freedberg K, Lipsitch M . Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa. Epidemiol Infect. 2019; 147:e122. PMC: 6452860. DOI: 10.1017/S0950268818003497. View

Cornell M, Johnson L, Schomaker M, Tanser F, Maskew M, Wood R . Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. Lancet HIV. 2015; 2(9):e368-75. PMC: 4603282. DOI: 10.1016/S2352-3018(15)00113-7. View

10.

Meintjes G, Moorhouse M, Carmona S, Davies N, Dlamini S, van Vuuren C . Adult antiretroviral therapy guidelines 2017. South Afr J HIV Med. 2018; 18(1):776. PMC: 5843236. DOI: 10.4102/sajhivmed.v18i1.776. View

11.

Etoori D, Wringe A, Kabudula C, Renju J, Rice B, Gomez-Olive F . Misreporting of Patient Outcomes in the South African National HIV Treatment Database: Consequences for Programme Planning, Monitoring, and Evaluation. Front Public Health. 2020; 8:100. PMC: 7154050. DOI: 10.3389/fpubh.2020.00100. View

12.

Wagenaar B, Sherr K, Fernandes Q, Wagenaar A . Using routine health information systems for well-designed health evaluations in low- and middle-income countries. Health Policy Plan. 2015; 31(1):129-35. PMC: 4751224. DOI: 10.1093/heapol/czv029. View

13.

Peter T, Zeh C, Katz Z, Elbireer A, Alemayehu B, Vojnov L . Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing. J Int AIDS Soc. 2017; 20 Suppl 7. PMC: 5978645. DOI: 10.1002/jia2.25008. View

14.

Lippman S, El Ayadi A, Grignon J, Puren A, Liegler T, Francois Venter W . Improvements in the South African HIV care cascade: findings on 90-90-90 targets from successive population-representative surveys in North West Province. J Int AIDS Soc. 2019; 22(6):e25295. PMC: 6562149. DOI: 10.1002/jia2.25295. View

15.

Osler M, Hilderbrand K, Hennessey C, Arendse J, Goemaere E, Ford N . A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. J Int AIDS Soc. 2014; 17:18908. PMC: 4005043. DOI: 10.7448/IAS.17.1.18908. View

16.

Johnson L, Chiu C, Myer L, Davies M, Dorrington R, Bekker L . Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016; 9:30314. PMC: 4901512. DOI: 10.3402/gha.v9.30314. View

17.

Davies M, Boulle A, Fakir T, Nuttall J, Eley B . Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008; 8:34. PMC: 2533648. DOI: 10.1186/1471-2431-8-34. View

18.

Johnson L, Dorrington R, Moolla H . Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. South Afr J HIV Med. 2018; 18(1):694. PMC: 5843157. DOI: 10.4102/sajhivmed.v18i1.694. View

19.

Takuva S, Brown A, Pillay Y, Delpech V, Puren A . The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets. AIDS. 2017; 31(4):545-552. DOI: 10.1097/QAD.0000000000001340. View

20.

Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M . Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011; 11(12):942-51. PMC: 4250825. DOI: 10.1016/S1473-3099(11)70181-5. View